Charleston, SC -- (SBWIRE) -- 01/16/2014 -- otcstockcenter.com, provide information specifically for trades in the micro-cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Let’s have a look on Few Hot Stocks: Plandai Biotechnology Inc (OTCMKTS:PLPL), Medbox Inc (OTCMKTS:MDBX), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY)
Plandai Biotechnology Inc (OTCMKTS:PLPL) was trading higher by 0.040 points or 7.27% to $0.590.So far, around 1.30 million shares have changed hands in this session. After opening at $0.61, the stock hit as high as $0.64. However, it traded between $0.04 and$0.82 over the last twelve months. Plandai Biotechnology, Inc., formerly Diamond Ranch Foods, Ltd., through its subsidiaries focuses on the farming of whole fruits, vegetables and live plant material and the production of functional foods and botanical extracts for the health and wellness industry. Its principle holdings consist of land, farms and infrastructure in South Africa.
For How Long PLPL will Fight for Profitability? Read This Trend Analysis report
Medbox Inc (OTCMKTS:MDBX) was at $37.70, showing a -8.16% decrease. Around 156,489.00 shares have been traded, versus an-average trading volume of 243,842.00 shares. The company is now valued at around $605.49 million. Medbox Inc. (Medbox) offers a machine that dispenses medication to individuals based on biometric identification (fingerprint sample). The machine allows pharmacies, hospitals, doctors' offices, and alternative medicine clinics to manage employee possession of sensitive drugs.
Has MDBX Found The Bottom And Ready To Gain Momentum? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) moved -7.86 per cent lower at $2.58 and is trading between $2.30 and $2.84 after opening the day at $2.83. Its performance over the last five days remained 289.39%, which stands at 289.39% for a month. Going back further than one month, 1-year performance after recent close was 289.39%. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications.
Why Should Investors Buy PVCT After the Recent Fall? Just Go Here and Find Out
Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) shares decline today, losing 1.36 per cent to $74.60. The stock is up around 1.3% in 2013 and 11.05% for the last 12 months. Around 216,782.00 shares changed hands so far in this session compared to an-average trading volume of 622,894.00 shares. Nestle SA is a Switzerland-based holding company of the Nestle Group (the Group) and is principally engaged in the development and production of food and beverage.
Will NSRGY Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Center:
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)